(Q38290962)

1 September 2017

1 reference

title

Sleep disturbances and dementia (English)

1 reference

1 September 2017

0 references

Gabriele Cipriani

1

1 reference

1 September 2017

Claudio Lucetti

series ordinal

2

1 reference

1 September 2017

Sabrina Danti

series ordinal

3

1 reference

1 September 2017

Angelo Nuti

series ordinal

4

1 reference

1 September 2017

publication date

16 December 2014

1 reference

Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society

1 September 2017

published in

1 reference

1 September 2017

volume

15

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

65-74

1 reference

How to fix a broken clock

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep disorders and aging: understanding the causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Symptoms of sleep disturbance in persons with Alzheimer's disease and normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Hallucinations and sleep-wake cycle in Alzheimer's disease: a questionnaire-based study in 218 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Symposium: Cognitive processes and sleep disturbances: Sleep/wake patterns in Alzheimer's disease: relationships with cognition and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Is Alzheimer's disease related to a deficit or malfunction of rapid eye movement (REM) sleep?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep disorders in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep disturbance in association with elevated pulse rate for prediction of mortality--consequences of mental strain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep, insomnia and falls in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Determinants of carer stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

A follow up study of depression in the carers of dementia sufferers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep Problems and Institutionalization of the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Melatonin rhythmicity: effect of age and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Circadian rest-activity rhythm disturbances in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Nursing home placement, day care use, and cognitive decline in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Caregiving as a risk factor for mortality: the Caregiver Health Effects Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Trazodone for the treatment of sleep disorders in dementia: an open-label, observational and review study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Diagnosis and treatment of sleep disorders in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Duration and placement of sleep in a "disentrained" environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Current treatments for sleep disturbances in individuals with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Hypothalamic integration of central and peripheral clocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Predictors of observed sleep/wakefulness in residents in long-term care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

REM sleep behavior disorder: from dreams to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

REM sleep behavior disorder in a patient with frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Disrupted sleep and circadian patterns in frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Rapid eye movement sleep disturbances in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep-wake cycles in multi-infarct dementia and dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep disturbance correlates with white matter hyperintensity in patients with subcortical ischemic vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Fatal familial insomnia: clinical features and molecular genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep-wake cycle abnormalities in fatal familial insomnia. Evidence of the role of the thalamus in sleep regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Anxiety and nighttime behavioral disturbances. Awakenings in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep disturbance in mild to moderate Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep disturbances in Alzheimer's disease are associated with neuropsychiatric symptoms and antidementia treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Sleep problems associated with behavioral and psychological symptoms as well as cognitive functions in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Insomnia in an 80-year-old population: relationship to medical, psychological and social factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Acupuncture increases nocturnal melatonin secretion and reduces insomnia and anxiety: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

A critique of the evidence base for non-pharmacological sleep interventions for persons with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Daily rhythm of serum melatonin in patients with dementia of the degenerate type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Pineal calcification in Alzheimer's disease: an in vivo study using computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Melatonin in Alzheimer's disease and other neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Clinical aspects of melatonin intervention in Alzheimer's disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Ramelteon for the treatment of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Haloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Aricept-induced nightmares in Alzheimer's disease: 2 case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPSYG.12069

21 January 2018

Identifiers

DOI

10.1111/PSYG.12069

1 reference

1 September 2017

1 reference